macular telangiectasia type 1
Conditions
Brief summary
Change in central retinal thickness between M0 and M6, measured by SD-OCT
Detailed description
Evolution between M0 and M6 of visual acuity measured on the ETDRS scale, Evolution between M0 and M6 of retinal volume measured by SD-OCT, Evolution between M0 and M6 of perifoveolar capillary density in the superficial and deep capillary plexus measured by OCTA, Evolution between M0 and M6 of number of abnormal microvascular lesions in the superficial and deep capillary plexus measured by OCTA, Ocular safety (sustainable elevation of ocular pressure, cataract, intraocular inflammation, infectious endophthalmitis, retinal detachment, retinal tear, vitreous or subretinal hemorrhage
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in central retinal thickness between M0 and M6, measured by SD-OCT | — |
Secondary
| Measure | Time frame |
|---|---|
| Evolution between M0 and M6 of visual acuity measured on the ETDRS scale, Evolution between M0 and M6 of retinal volume measured by SD-OCT, Evolution between M0 and M6 of perifoveolar capillary density in the superficial and deep capillary plexus measured by OCTA, Evolution between M0 and M6 of number of abnormal microvascular lesions in the superficial and deep capillary plexus measured by OCTA, Ocular safety (sustainable elevation of ocular pressure, cataract, intraocular inflammation, infectious endophthalmitis, retinal detachment, retinal tear, vitreous or subretinal hemorrhage | — |
Countries
France